77 related articles for article (PubMed ID: 10736216)
21. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE
Stem Cells; 2000; 18(4):230-44. PubMed ID: 10924089
[TBL] [Abstract][Full Text] [Related]
22. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
24. [Finding the traces of the HIV selection].
Espinosa E
Rev Latinoam Microbiol; 2006; 48(2):84-90. PubMed ID: 17578078
[TBL] [Abstract][Full Text] [Related]
25. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
[TBL] [Abstract][Full Text] [Related]
26. HIV CTL escape: at what cost?
Smith SM
Retrovirology; 2004 May; 1():8. PubMed ID: 15169568
[TBL] [Abstract][Full Text] [Related]
27. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
28. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
[TBL] [Abstract][Full Text] [Related]
29. Peptide immunogens designed to enhance immune responses against human immunodeficiency virus (HIV) mutant strains: a plausible means of preventing viral persistence.
Hewer R; Meyer D
J Theor Biol; 2005 Mar; 233(1):85-90. PubMed ID: 15615622
[TBL] [Abstract][Full Text] [Related]
30. HIV evolution: CTL escape mutation and reversion after transmission.
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
[TBL] [Abstract][Full Text] [Related]
31. Macrophages exposed to lymphotropic and monocytotropic HIV induce similar CTL responses despite differences in productive infection.
Knox KS; Day RB; Wood KL; Kohli LL; Hage CA; Foresman BH; Schnizlein-Bick CT; Twigg HL
Cell Immunol; 2004 Jun; 229(2):130-8. PubMed ID: 15474527
[TBL] [Abstract][Full Text] [Related]
32. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
33. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
34. Defective escape mutants of HIV.
Berry RM; Nowak MA
J Theor Biol; 1994 Dec; 171(4):387-95. PubMed ID: 7869736
[TBL] [Abstract][Full Text] [Related]
35. Immune impairment in HIV infection: existence of risky and immunodeficiency thresholds.
Iwami S; Miura T; Nakaoka S; Takeuchi Y
J Theor Biol; 2009 Oct; 260(4):490-501. PubMed ID: 19577579
[TBL] [Abstract][Full Text] [Related]
36. The coalescence of intrahost HIV lineages under symmetric CTL attack.
Leviyang S
Bull Math Biol; 2012 Aug; 74(8):1818-56. PubMed ID: 22644341
[TBL] [Abstract][Full Text] [Related]
37. Sampling HIV intrahost genealogies based on a model of acute stage CTL response.
Leviyang S
Bull Math Biol; 2012 Mar; 74(3):509-35. PubMed ID: 21739335
[TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of HIV infection.
Pantaleo G; Fauci AS
Annu Rev Microbiol; 1996; 50():825-54. PubMed ID: 8905100
[TBL] [Abstract][Full Text] [Related]
39. A mathematical model for HIV dynamics with multiple infections: implications for immune escape.
Deng Q; Guo T; Qiu Z; Chen Y
J Math Biol; 2024 May; 89(1):6. PubMed ID: 38762831
[TBL] [Abstract][Full Text] [Related]
40. Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection.
Burg D; Rong L; Neumann AU; Dahari H
J Theor Biol; 2009 Aug; 259(4):751-9. PubMed ID: 19389409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
